Elongation of Foveal Tissue After Macular Hole Surgery
Asymmetric Elongation of Foveal Tissue After Macular Hole Surgery and Its Impact on Metamorphopsia
1 other identifier
interventional
31
1 country
1
Brief Summary
In our experience, elongation of foveal tissue after macular hole surgery which was undetectable by conventional time-domain optical coherence tomography was often observed on spectral-domain optical coherence tomography images. Elongation of tissues inevitably induces some degree of disorganization of tissue microstructure. The purpose of the present study was to evaluate elongation profile of foveal tissue after macular hole surgery and to investigate its impact on visual acuity and metamorphopsia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2009
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2011
CompletedFirst Submitted
Initial submission to the registry
November 6, 2011
CompletedFirst Posted
Study publicly available on registry
November 16, 2011
CompletedNovember 17, 2011
November 1, 2011
1.6 years
November 6, 2011
November 16, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Changes in the inter-outer plexiform layer distance
the spectral domain optical coherence tomography scannings were performed at first postoperative visit, 1 month, 2 months, and 6 months after macular hole surgery. The inter-outer plexiform layer distance was measured based on optical coherence tomography images at defined time points
first postoperative visit, 1 month, 2 months, and 6 months after macular hole surgery
Changes in best-corrected visual acuity
Best-corrected visual acuity was measured using early treatment diabetic retinopathy study chart at defined time points
first postoperative visit, 2 months, and 6 months after macular hole surgery
Changes in degree of metamorphopsia
The degree of metamorphopsia was measured using Metamorphopsia-chart at defined time points
first postoperative visit, 2 months, and 6 months after macular hole surgery
Degree of percent asymmetric elongation on the same plane
The horizontal percent asymmetry was calculated as (nasal distance - temporal distance)/(nasal distance + temporal distance). The vertical percent asymmetry was also calculated as (superior distance - inferior distance)/ (superior distance + inferior distance.
at 6 months postoperative
Degree of horizontal-vertical percent asymmetry
The percent asymmetry was calculated as (horizontal inter-outer plexiform layer distance - vertical inter-outer plexiform layer distance)/(horizontal inter-outer plexiform layer distance + vertical inter-outer plexiform layer distance).
at 6 months postoperative
Interventions
A three-port standard pars plana vitrectomy was performed by a single surgeon using a 23-gauge vitrectomy system, either Associate®(Dutch Ophthalmic Research Center. Inc., Zuidland, The Netherlands) or Accurus®(Alcon Laboratories Inc., Fort Worth, USA), with one step scleral tunnel incision. In all cases, the peeling of the internal limiting membrane, approximately 1 disc diameter area from center of MH was conducted without assistance of dyes followed by complete fluid-gas exchange using 25% sulfur hexafluoride gas. Combined cataract surgery was performed in patients with visually significant cataracts or with incipient cataract in the subjects older than 60 years. All patients were instructed to maintain a face-down position for at least 7 days postoperatively.
Eligibility Criteria
You may qualify if:
- Patients who were diagnosed with idiopathic macular hole
You may not qualify if:
- traumatic macular hole
- evidence of ocular inflammation, diabetic retinopathy, hypertensive retinopathy, and retinal vasculitis, media opacity that would influence visual acuity or preclude acquisition of clear spectral domain optical coherence tomography images
- presence of cataract judged to affect visual function, -6.0 diopters or more of spherical equivalent, prominent staphyloma
- history of intraocular surgery other than uncomplicated cataract surgery, other ocular diseases that may influence the macular microstructure or visual function
- patients with indistinct intraretinal structure on spectral domain optical coherence tomography images
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Samsung Medical Center
Seoul, 135-710, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 6, 2011
First Posted
November 16, 2011
Study Start
September 1, 2009
Primary Completion
April 1, 2011
Study Completion
October 1, 2011
Last Updated
November 17, 2011
Record last verified: 2011-11